Diabetes Center Research Update

The Diabetes Research and Training Center (DRTC)under the umbrella of the Vanderbilt Diabetes Centerincludes more than 120 doctors and scientists in 15 departments. Our goal is to understand and develop new treatments for diabetes, obesity and metabolism disorders.

Here's a brief sample of some recent research highlights:

The Diabetes Control and Complications Trial is a landmark study that showed how important blood glucose control is for preventing and reducing many complications of diabetes. This study began at Vanderbilt and continues to yield new insights. Learn more.

David Piston, Ph.D. and colleagues discovered that "brown fat" may be useful in developing new treatments for type 1 and type 2 diabetes. Learn more.

Julie Pendergast and colleagues reported in the Proceedings of the National Academy of Sciences that

Vanderbilt doctors in the nationwide TrialNet study are testing new ways to prevent or delay the onset of type 1 diabetes. Learn more.

Through the exceptional capabilities and caring spirit of its people, Vanderbilt will lead in improving the healthcare of individuals and communities regionally, nationally and internationally. We will combine our transformative learning programs and compelling discoveries to provide distinctive personalized care.